Acquisitions, Sherman Act, FTC Act

Antitrust Scrutiny of Investors Under a New Administration

Baker Botts L.L.P. on 6/12/2025

Under the old guard of the prior administration, private equity was repeatedly under fire for alleged “flip and strip” tactics that were supposedly “at odds with competition.” Now, with new enforcers in place, a different...more

FTC Focus: Private Equity Investments In Healthcare

Proskauer Rose LLP on 8/2/2024

U.S. antitrust regulators, particularly the Federal Trade Commission, have been stepping up scrutiny of private equity investments in healthcare. On March 5, the FTC, along with the U.S. Department of Justice and the U.S....more

FTC and DOJ launch public inquiry on serial acquisitions and roll-up strategies

Hogan Lovells on 6/4/2024

On May 23, 2024, the U.S. Federal Trade Commission (FTC) and the Department of Justice Antitrust Division (DOJ) (the Agencies) published a Request for Information (the “May 2024 RFI”) to solicit public comments to help...more

Biden Administration Enlists Public in Effort to Identify Potential Antitrust Violations in Healthcare Sector

Bradley Arant Boult Cummings LLP on 4/23/2024

The Federal Trade Commission (FTC), Department of Justice (DOJ) and Department of Health and Human Services (HHS) recently announced the launch of “an easily accessible online portal for the public to report health care...more

Heard at the 2023 Spring Meeting: Part 1

McDermott Will & Emery on 4/4/2023

The American Bar Association’s Antitrust Law Section recently held its annual Spring Meeting in Washington, DC, featuring updates from federal, state, and international antitrust enforcers and in-depth commentary on leading...more

FAQ About the FTC's Controversial New "Unfair Methods of Competition" Policy

Jones Day on 11/30/2022

The Federal Trade Commission (“FTC”) released a new Policy Statement of its enforcement priorities for Section 5 of the FTC Act, which makes unlawful “unfair methods of competition.” Since the passage of the FTC Act in 1914,...more